There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" NVO shares. View NVO analyst ratings or view top-rated stocks.
Is Novo Nordisk (NVO) a good stock to buy?
Novo Nordisk ( NVO 0.35%) has been a fantastic, market-beating stock to own for the past decade. Its 10-year return is an incredible 527%, which dwarfs the S&P 500 's 182% gain during the same period. But it wasn't until 2022 that the stock really took off. Up until then, its returns were more comparable to that of the broader market.
Does Novo Nordisk (NVO) pay a dividend?
Novo Nordisk A/S (NYSE:NVO) pays an annual dividend of $1.33 per share and currently has a dividend yield of 1.00%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 45.86%. This payout ratio is at a healthy, sustainable level, below 75%.
